Literature DB >> 8222134

Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep. Systolic dysfunction precedes diastolic dysfunction.

T Aoyagi1, A M Fujii, M F Flanagan, L W Arnold, K W Brathwaite, S D Colan, I Mirsky.   

Abstract

BACKGROUND: Patients with aortic stenosis have a period of compensated left ventricular hypertrophy but may eventually develop congestive heart failure. Previous experimental studies showed either normal myocardial contractility in mild short-term pressure overload or myocardial dysfunction with severe pressure overload. Transition from compensated left ventricular hypertrophy to myocardial dysfunction has not been experimentally demonstrated in an adult large animal. Controversial issues in pressure-overload hypertrophy include whether the left ventricular dysfunction is due to insufficient hypertrophy (afterload mismatch) or to intrinsic myocardial dysfunction and whether diastolic dysfunction precedes systolic dysfunction. METHODS AND
RESULTS: We induced left ventricular hypertrophy (41% increase in left ventricular to body weight ratio) by gradually tightening a hydraulic constrictor around the ascending aorta in 9 chronically instrumented conscious sheep. Afterload (end-systolic stress) elevation remained constant (approximately 33% greater than baseline) by adjustment of the aortic constrictor over 6 weeks, gradually increasing left ventricular pressure (from 117 +/- 6 to 163 +/- 5 mm Hg) as hypertrophy developed. Four sets (baseline, 2 weeks, 4 weeks, and 6 weeks) of serial hemodynamic studies were performed in each animal with beta-blockade, first with and then without aortic constriction to mechanically match loading conditions. Stepwise methoxamine infusion was performed to obtain load-independent assessment of myocardial contractility. Midwall shortening (P < .05) and shortening rate (P < .05) at mechanically matched loading conditions showed that myocardial dysfunction developed between the fourth and the sixth week. Shortening-preload-afterload (P < .05) and shortening rate-preload-afterload (P < .05) relations, load-independent contractility indices based on the systolic myocardial stiffness concept, also revealed depressed myocardial contractility at the sixth week. Time constant of left ventricular isovolumic relaxation and diastolic myocardial stiffness constant did not change over the 6 weeks.
CONCLUSIONS: Transition from normal myocardial contractility to myocardial dysfunction was demonstrated. This transition occurred even when the elevation of afterload remained constant as hypertrophy incompletely adapted to increasing left ventricular pressure. Systolic dysfunction preceded diastolic dysfunction in this model.

Entities:  

Mesh:

Year:  1993        PMID: 8222134     DOI: 10.1161/01.cir.88.5.2415

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

2.  A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarction.

Authors:  Domenico G Della Rocca; Bradley J Willenberg; Leonardo F Ferreira; Prateek S Wate; John W Petersen; Eileen M Handberg; Tong Zheng; Dennis A Steindler; Naohiro Terada; Christopher D Batich; Barry J Byrne; Carl J Pepine
Journal:  Med Hypotheses       Date:  2012-08-28       Impact factor: 1.538

3.  Linking pediatric obesity to subclinical alterations in cardiac structure and function.

Authors:  Justin P Zachariah; Charlotte B Ingul; Gerald R Marx
Journal:  JACC Cardiovasc Imaging       Date:  2014-10-14

Review 4.  Vascular endothelial growth factor in heart failure.

Authors:  Ziad Taimeh; John Loughran; Emma J Birks; Roberto Bolli
Journal:  Nat Rev Cardiol       Date:  2013-07-16       Impact factor: 32.419

Review 5.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 6.  Small and large animal models in cardiac contraction research: advantages and disadvantages.

Authors:  Nima Milani-Nejad; Paul M L Janssen
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

7.  Mechanical stimuli for left ventricular growth during pressure overload.

Authors:  J Mojumder; J S Choy; S Leng; L Zhong; G S Kassab; L C Lee
Journal:  Exp Mech       Date:  2020-08-11       Impact factor: 2.808

8.  The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.

Authors:  Huixin Guo; Baoxin Liu; Lei Hou; Erlinda The; Gang Li; Dongzhi Wang; Qiqiang Jie; Wenliang Che; Yidong Wei
Journal:  Int J Mol Med       Date:  2015-03-02       Impact factor: 4.101

9.  Nuclear accumulation of myocyte muscle LIM protein is regulated by heme oxygenase 1 and correlates with cardiac function in the transition to failure.

Authors:  Anju Paudyal; Sukriti Dewan; Cindy Ikie; Benjamin J Whalley; Pieter P de Tombe; Samuel Y Boateng
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

Review 10.  Large Animal Models of Heart Failure: A Translational Bridge to Clinical Success.

Authors:  Kleiton Augusto Santos Silva; Craig A Emter
Journal:  JACC Basic Transl Sci       Date:  2020-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.